The results suggest dupilumab may offer consistent benefit across patient subgroups without the need for extensive ...

Northwestern Medicine investigators have uncovered a missing link behind the harmful effects of autoantibodies linked to ...

FDA grants Orphan Drug Designation to SignaBlok's first-in-class, new mechanism-based TREM-1 peptide inhibitor to treat ...

Timely resolution of inflammation induced by standard-of-care cancer treatments can be a common approach to prevent ...

Alzheimer's disease is most commonly associated with memory impairment, disorientation, and irreversible neurodegenerative ...

Long COVID remains a frustrating medical mystery, affecting up to 1 in 10 people long after the initial infection fades. Now, scientists have uncovered a crucial clue hidden deep within the immune ...

Among Americans under 50, the overall cancer mortality has plummeted by 44% over the last quarter-century. Better diagnostic ...

Submitted GraftAssureDx™ for kidney transplant rejection testing for FDA review on Wednesday, March 25Welcomed second ...

Microscopic plastic particles we unknowingly consume may be triggering brain inflammation and linked to Alzheimer’s and ...

Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology of TNX-1900 for ...

Harrington Prize for Innovation in Medicine recognizes pioneering work in prostate cancer diagnosis and treatment CLEVELAND, March 24, 2026 /PRNewswire/ -- The thirteenth annual Harrington Prize for ...

Tuberculosis remains a major global health threat, and symptom-based case detection fails to interrupt community transmission.1 Nearly half of tuberculosis cases are missed by current strategies, and ...